PETS PetMed Express, Inc. - Common Stock
Tentang PetMed Express, Inc. - Common Stock Tinjauan perusahaan dari Wikipedia
PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.
Baca selengkapnya
PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.
Business model
PetMed Express is an online pharmacy that sells prescription and non-prescription pet medication and nutritional supplements. It can only fill prescriptions written by veterinarians, and competes with veterinarians who derive some of their income from selling pet medication.
History
Petmed Express was founded in Florida in 1996 by Marc Puleo. Puleo was an anesthesiologist who wanted to open a mail-order business for human prescriptions that also sold pet accessories. He shifted his focus to pet medicines due to Merck already heavily controlling the human prescription market. The company initially grew through word of mouth, television commercials, and its catalogs.
Its stock was traded on the OTC Bulletin Board under the symbol PETS from September 1997 until March 2000; in March 2000 the company began the process of becoming listed on the National Quotation Bureau Electronic Quotation Service and became responsible for reporting to the SEC.
Until 2002 PetMed Express and a company called Savemax Inc. operated in the same premises, shared staff, and operated under the same pharmacy licenses. According to the lawyer for both companies, Savemax was formed because of "a concern over PetMed's liability, and whether it [would] continue." From 1999 to 2002, PetMed Express and SaveMax were charged with violating the pharmaceutical law in several states. In one instance it was fined by the Environmental Protection Agency for selling drugs in metric doses, and has also received a warning letter from the FDA for selling misbranded drugs. In 1999, PetMed Express settled charges with the Florida Pharmacy Board for selling drugs that did not have prescriptions, false advertising, poor record keeping, and not labelling drugs correctly.
In addition to pet medications, PetMed Express also sold pet accessories such as leashes. In 2000, Tricon Holdings invested $2 million into the company. The company also hired Menderes Akdag as CEO in 2001. It discontinued 5,000 products and began focusing strictly on medicine-related items.
In 2002, PetMed Express and Savemax were fined by the EPA for selling prescription drugs illegally. The drugs were made by Novartis for sale in Europe and Australia and the doses and labelling were not FDA-approved. Also in 2002, PetMed Express, this time with Savemax, the company reached a settlement with the Florida Pharmacy Board for contracting with veterinarians to write prescriptions for animals they had never examined. The Florida board provided information to national boards and encouraged other state boards to take actions against veterinarians who had worked with PetMed Express to provide prescriptions for animals they had not examined. In the same year, the company settled similar charges in Ohio. In November 2002, the pharmacy board in Texas filed a lawsuit charging PetMed Express with dispensing veterinary drugs without prescriptions. The case was settled in 2006 with a $50,000 fine and three years' probation.
In 2004 a securities class action lawsuit was filed against the company, claiming that the company was not candid about the difficulty in getting prescriptions authorized by veterinarians. In 2005, the lawsuits were voluntarily dismissed by the plaintiffs. Puleo stepped down from executive leadership with the company the same year. Another shareholder lawsuit was filed against the company in 2018, claiming that it marketed dangerous animal drugs to humans. The lawsuit was later dismissed by plaintiffs after investigation of the claims.
As announced by PetMed Express Inc. in a regulatory filing published on Friday, June 4, 2021, Menderes Akdag, chief executive officer, leaves the online pet pharmacy after around 20 years in the role. PetMed said: “On May 28, 2021, the Board of Directors of PetMed Express, Inc. (the “Company”) notified Menderes Akdag, President and Chief Executive Officer, that the Company will not extend Mr. Akdag’s employment agreement with the Company and that the employment agreement would therefore end on July 30, 2021 in accordance with the scheduled end date of the agreement. The Company has presented a proposal to Mr. Akdag regarding the continuation of his role as President and Chief Executive Officer for a transition period following July 30, 2021 until a new CEO is appointed.” Matthew N. Hulett, the former president of language learning giant Rosetta Stone, was named CEO and president effective August 30, 2021. Hulett entered into a three-year employment agreement with PetMed Express at a $500,000 base salary per year. He also received 90,000 shares of restricted stock and 510,000 shares of performance restricted stock.
In April 2022, the company signed a partnership with Vetster, a telehealth veterinary company. As part of the agreement, PetMeds will be the exclusive eCommerce provider of Vetster medications, and Vetster will be the exclusive provider of telehealth services to PetMeds customers.
In 2023, PetMed partnered with Pumpkin Pet Insurance a pet insurance provider. In 2025, PetMed launched PetHealthMD a pet care insurance provider.
Recognition
The company was picked 4th among Forbes magazine's 200 Best Small Business Companies in 2006 and number 6 in 2007. BusinessWeek named PetMed Express number 27 of its top 100 "Hot Growth Companies" in 2006.
== References ==
Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗
PETS Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
PETS Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Dividen Yield, rasio pembayaran, riwayat dividen, CAGR 5 tahun
| Tanggal ex-dividen | Jumlah |
|---|---|
| 11 Agu 2023 | $0,3000 |
| 5 Juni 2023 | $0,3000 |
| 16 Feb. 2023 | $0,3000 |
| 17 Nov. 2022 | $0,3000 |
| 11 Agu 2022 | $0,3000 |
| 19 Mei 2022 | $0,3000 |
| 4 Feb. 2022 | $0,3000 |
| 5 Nov. 2021 | $0,3000 |
| 5 Agu 2021 | $0,3000 |
| 13 Mei 2021 | $0,3000 |
| 29 Jan. 2021 | $0,2800 |
| 6 Nov. 2020 | $0,2800 |
| 30 Juli 2020 | $0,2800 |
| 14 Mei 2020 | $0,2800 |
| 31 Jan. 2020 | $0,2700 |
| 1 Nov. 2019 | $0,2700 |
| 1 Agu 2019 | $0,2700 |
| 16 Mei 2019 | $0,2700 |
| 1 Feb. 2019 | $0,2700 |
| 2 Nov. 2018 | $0,2700 |
PETS Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
- Beli Kuat 0 0,0%
- Beli 0 0,0%
- Tahan 2 33,3%
- Jual 2 33,3%
- Jual Kuat 2 33,3%
Target Harga 12 Bulan
1 analis · 2026-08-14Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
| Periode | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|
| 31 Maret 2027 | $-0.28 | $0.12 | — |
| 31 Des. 2026 | $-0.19 | $-0.18 | — |
| 30 Juni 2026 | $-0.28 | $0.12 | -0.40% |
| 31 Maret 2026 | $-0.19 | $-0.18 | -0.01% |
| 31 Des. 2025 | $-0.50 | $-0.06 | -0.44% |
| 30 Juni 2025 | $-1.65 | $-0.07 | -1.6% |
| 31 Maret 2025 | $-0.56 | $-0.05 | -0.52% |
| 31 Des. 2024 | $-0.03 | $-0.01 | -0.02% |
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| PETS | $49M | -0.8 | -21.1% | -32.0% | -100.4% | 28.1% |
| BARK | — | -2.2 | -18.4% | — | — | — |
| PEW | $90M | -23.2 | 3.6% | -2.6% | -2.3% | 11.7% |
| SPWH | $52M | -1.1 | 0.96% | -4.1% | -25.2% | 30.9% |
| GROV | $46M | -3.2 | -14.6% | -6.7% | 75.6% | 53.7% |
| LESL | $46M | -0.2 | -6.6% | -19.1% | 70.0% | 35.4% |
| ULTA | $27.83B | 24.6 | 9.7% | 9.3% | 42.7% | 39.1% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi 16
| Metrik | Tren | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $179M | $227M | $274M | $248M | $272M | $304M | $284M | $283M | $274M | $249M | $235M | · | |
| Cost of Revenue | · | $158M | $189M | $171M | $195M | $219M | $203M | $188M | $176M | $170M | $158M | · | |
| Gross Profit | $50M | $69M | $85M | $77M | $77M | $84M | $81M | $95M | $98M | $79M | $76M | · | |
| SG&A Expense | $51M | $39M | $55M | $42M | $31M | $30M | $25M | $25M | $24M | $23M | $21M | · | |
| Operating Expenses | $109M | $71M | $93M | $70M | $53M | $54M | $50M | $49M | $46M | $42M | $44M | · | |
| Operating Income | $-59M | $-2M | $-8M | $6M | $24M | $31M | $31M | $46M | $52M | $37M | $32M | · | |
| Interest Income | · | · | · | $2M | $335.0K | $314.0K | $2M | $2M | $658.0K | $141.0K | $190.0K | · | |
| Other Non-op | $803.0K | $758.0K | $1M | $944.0K | $1M | $1M | $1M | $1M | $995.0K | $300.0K | $63.0K | · | |
| Pretax Income | $-57M | $-587.0K | $-6M | $7M | $24M | $31M | $34M | $49M | $54M | $38M | $33M | · | |
| Income Tax | $-73.0K | $6M | $1M | $2M | $5M | $7M | $8M | $11M | $17M | $14M | $12M | · | |
| Net Income | $-57M | $-6M | $-7M | $5M | $19M | $24M | $26M | $38M | $37M | $24M | $21M | · | |
| EPS (Basic) | $-2.74 | $-0.30 | $-0.37 | $0.25 | $0.93 | $1.19 | $1.29 | $1.84 | $1.83 | $1.18 | $1.02 | · | |
| EPS (Diluted) | $-2.74 | $-0.30 | $-0.37 | $0.25 | $0.92 | $1.19 | $1.29 | $1.84 | $1.82 | $1.17 | $1.02 | · | |
| Shares (Basic) | 20,921,361 | 20,596,022 | 20,395,959 | 20,274,786 | 20,175,930 | 20,060,000 | 20,041,000 | 20,461,000 | 20,346,000 | 20,232,000 | 20,124,000 | · | |
| Shares (Diluted) | 20,921,361 | 20,596,022 | 20,395,959 | 20,339,002 | 20,357,820 | 20,119,000 | 20,055,000 | 20,491,000 | 20,433,000 | 20,378,000 | 20,254,000 | · | |
| EBITDA | $-49M | $6M | $-1M | $6M | $26M | $38M | $31M | $46M | $52M | · | · | · |
Neraca 23
| Metrik | Tren | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $21M | $55M | $55M | $104M | $111M | $119M | $104M | $101M | $78M | $59M | $38M | $36M | |
| Receivables | $2M | $2M | $3M | $2M | $2M | $3M | $4M | $3M | $2M | $2M | · | · | |
| Inventory | $14M | $16M | $29M | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $6M | $5M | $6M | $5M | $5M | $5M | $4M | $1M | $882.0K | $1M | · | · | |
| Current Assets | $44M | $79M | $94M | $130M | $151M | $161M | $129M | $126M | $105M | $82M | · | · | |
| PP&E (Net) | $26M | $29M | $27M | $26M | $24M | $25M | $25M | $27M | $29M | $30M | · | · | |
| PP&E (Gross) | $58M | $54M | $47M | $41M | $36M | $36M | $36M | $36M | $35M | $34M | · | · | |
| Accum. Depreciation | $32M | $25M | $20M | $15M | $12M | $10M | $11M | $8M | $6M | $4M | · | · | |
| Goodwill | $0 | $27M | $27M | $0 | · | · | · | · | · | · | · | · | |
| Intangibles | $5M | $8M | $11M | $860.0K | $860.0K | $860.0K | $860.0K | $860.0K | $860.0K | $860.0K | · | · | |
| Total Assets | $81M | $149M | $170M | $167M | $180M | $187M | $155M | $154M | $135M | $113M | · | · | |
| Accounts Payable | $21M | $24M | $37M | $25M | $28M | $40M | $20M | $16M | $15M | $15M | · | · | |
| Current Liabilities | $52M | $63M | $72M | $58M | $56M | $45M | $24M | $19M | $18M | $18M | · | · | |
| Capital Leases | $42.0K | $535.0K | $995.0K | $0 | · | · | · | · | · | · | · | · | |
| Deferred Tax | $175.0K | $263.0K | $0 | $3M | $0 | $1M | $970.0K | $1M | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | $0 | $0 | · | · | · | · | · | · | · | |
| Total Liabilities | $52M | $64M | $73M | $58M | $56M | $46M | $25M | $20M | $19M | $19M | · | · | |
| Common Stock | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $20.0K | $20.0K | $21.0K | $21.0K | $21.0K | · | · | |
| Paid-in Capital | $20M | $19M | $25M | $18M | $12M | $7M | $4M | $12M | $9M | $7M | · | · | |
| Retained Earnings | $9M | $67M | $72M | $92M | $112M | $134M | $126M | $122M | $106M | $87M | · | · | |
| Stockholders' Equity | $29M | $85M | $97M | $110M | $123M | $125M | $120M | $135M | $116M | $93M | $83M | $75M | |
| Liabilities + Equity | $81M | $149M | $170M | $167M | $180M | $187M | $155M | $154M | $135M | $113M | · | · | |
| Shares Outstanding | 21,385,638 | 20,657,000 | 21,148,000 | 21,084,000 | 20,979,000 | 20,269,000 | 20,166,000 | 20,674,000 | 20,601,000 | 20,526,000 | · | · |
Arus Kas 15
| Metrik | Tren | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $9M | $7M | $7M | $4M | $3M | · | · | · | · | · | · | · | |
| Stock-based Comp | $1M | $-7M | $7M | $7M | $5M | $3M | $3M | $3M | $3M | $2M | $2M | · | |
| Deferred Tax | $-88.0K | $5M | $292.0K | $-2M | $-846.0K | $-1M | $-151.0K | $125.0K | $-92.0K | $2M | $-23.0K | · | |
| Amort. of Intangibles | $2M | $2M | $2M | $0 | · | · | · | · | · | · | · | · | |
| Other Non-cash | $18M | $5M | $-2M | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-28M | $5M | $4M | $28M | $18M | $40M | $39M | $45M | $37M | $47M | $21M | · | |
| CapEx | $5M | $5M | $5M | $5M | $2M | $2M | $2M | $620.0K | $703.0K | $11M | $20M | · | |
| Investing Cash Flow | $-5M | $-5M | $-41M | $-10M | $-2M | $-2M | $-2M | $-620.0K | $-703.0K | $-11M | $-4M | · | |
| Stock Repurchased | · | · | · | · | $0 | $0 | $11M | $0 | · | · | · | · | |
| Net Stock Activity | · | · | · | · | $0 | $0 | $-11M | · | · | · | · | · | |
| Dividends Paid | $21.0K | $181.0K | $12M | $25M | $24M | $23M | $22M | $22M | $17M | $16M | $15M | · | |
| Financing Cash Flow | $-299.0K | $-181.0K | $-12M | $-25M | $-24M | $-23M | $-33M | $-22M | $-17M | $-16M | $-15M | · | |
| Net Change in Cash | $-33M | $-576.0K | $-49M | $-7M | $-8M | $15M | $3M | $23M | $19M | $21M | $2M | · | |
| Taxes Paid | $52.0K | $525.0K | $130.0K | $4M | $6M | $10M | · | · | · | · | · | · | |
| Free Cash Flow | $-33M | $-395.0K | $-194.0K | $23M | $17M | $38M | $37M | $45M | $37M | · | · | · |
Profitabilitas 8
| Metrik | Tren | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 28.1% | 30.5% | 28.0% | 27.6% | 28.6% | 29.1% | · | · | 35.7% | · | · | · | |
| Operating Margin | -32.8% | -0.67% | -2.9% | 2.4% | 9.4% | 12.2% | · | · | 19.0% | · | · | · | |
| Net Margin | -32.0% | -2.8% | -2.7% | 2.0% | 7.7% | 9.9% | · | · | 13.6% | · | · | · | |
| Pretax Margin | -32.0% | -0.26% | -2.2% | 2.9% | 9.9% | 12.7% | · | · | 19.7% | · | · | · | |
| EBITDA Margin | -27.5% | 2.4% | -0.39% | 2.4% | 9.4% | 12.2% | · | · | 19.0% | · | · | · | |
| ROA | -49.8% | -3.9% | -4.4% | · | 11.6% | 17.8% | 16.7% | 26.1% | 30.1% | · | · | · | |
| ROE | -100.4% | -6.9% | -7.2% | · | 15.8% | 23.4% | 19.5% | 30.1% | 35.7% | · | · | · | |
| ROIC | -202.5% | -19.2% | -10.0% | · | 14.1% | 20.8% | 18.2% | 26.3% | 31.2% | · | · | · |
Likuiditas & Solvabilitas 2
| Metrik | Tren | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 1.3 | 1.3 | · | 4.5 | 3.6 | 5.3 | 6.8 | 5.8 | · | · | · | |
| Quick Ratio | 0.4 | 0.9 | 0.8 | · | 3.4 | 2.7 | 4.4 | 5.5 | 4.4 | · | · | · |
Efisiensi 3
| Metrik | Tren | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.6 | 1.4 | 1.7 | · | 1.5 | 1.8 | · | · | 2.2 | · | · | · | |
| Inventory Turnover | · | 7.1 | · | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 84.7 | 81.1 | 111.9 | · | 121.5 | 96.2 | · | · | 133.6 | · | · | · |
Tingkat Pertumbuhan 6
| Metrik | Tren | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -21.1% | -17.2% | 10.7% | -9.1% | -10.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -10.2% | -5.9% | -3.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -10.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | -72.8% | -22.7% | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | · | -72.5% | -21.8% | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | -75.3% | · | · | · | · | · | · | · | · | · | · | · |
Valuasi (TTM) 13
| Metrik | Tren | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $179M | $227M | $274M | $248M | $272M | $304M | $284M | $283M | $274M | $249M | $235M | $227M | |
| Net Income TTM | $-57M | $-6M | $-7M | $5M | $19M | $24M | $26M | $38M | $37M | $24M | $21M | $17M | |
| Market Cap | $49M | $87M | $101M | · | $541M | $713M | $580M | $471M | $860M | · | · | · | |
| P/E | -0.8 | -14.0 | -12.9 | 65.0 | 28.0 | 29.6 | 22.3 | 12.4 | 22.9 | 17.2 | 17.6 | 20.6 | |
| P/S | 0.3 | 0.4 | 0.4 | · | 2.0 | 2.3 | 2.0 | 1.7 | 3.1 | · | · | · | |
| P/B | 1.7 | 1.0 | 1.0 | · | 3.8 | 5.0 | 4.5 | 3.5 | 7.4 | · | · | · | |
| P / Tangible Book | 2.1 | 1.7 | 1.7 | 3.1 | 4.4 | 5.7 | · | · | · | · | · | · | |
| P / Cash Flow | -1.7 | 18.3 | 23.5 | · | 29.3 | 17.8 | 14.9 | 10.4 | 23.0 | · | · | · | |
| P / FCF | -1.5 | -219.1 | -522.2 | · | 32.3 | 18.9 | 15.9 | 10.6 | 23.5 | · | · | · | |
| Dividend Yield | 0.04% | 0.21% | 12.3% | · | 4.5% | 3.2% | 3.8% | 4.7% | 2.0% | · | · | · | |
| Earnings Yield | -120.2% | -7.2% | -7.7% | 1.5% | 3.6% | 3.4% | 4.5% | 8.1% | 4.4% | 5.8% | 5.7% | 4.8% | |
| Payout Ratio | -0.04% | -2.9% | -166.6% | 477.4% | 115.6% | 74.1% | 84.3% | 58.1% | 46.9% | · | · | · | |
| Annual Payout | $21.0K | $181.0K | $12M | $25M | $24M | $23M | $22M | $22M | $17M | $16M | $15M | · |
Laporan Laba Rugi 16
| Metrik | Tren | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $41M | $43M | $41M | $44M | $51M | $51M | $52M | $58M | $66M | $60M | $64M | $69M | $76M | $53M | $57M | $63M | |
| Cost of Revenue | $30M | · | · | $32M | $37M | $36M | $36M | $39M | $47M | $35M | $44M | $48M | $51M | $30M | $41M | $43M | |
| Gross Profit | $11M | $14M | $9M | $12M | $14M | $15M | $16M | $19M | $19M | $24M | $19M | $21M | $25M | $23M | $17M | $20M | |
| SG&A Expense | $11M | $11M | $12M | $14M | $13M | $12M | $11M | $10M | $5M | $14M | $13M | $12M | $16M | $12M | $10M | $10M | |
| Operating Expenses | $18M | $20M | $20M | $21M | $49M | $21M | $17M | $18M | $15M | $28M | $22M | $20M | $27M | $23M | $17M | $17M | |
| Operating Income | $-6M | $-6M | $-10M | $-8M | $-34M | $-6M | $-450.0K | $554.0K | $4M | $-4M | $-3M | $875.0K | $-2M | $-212.0K | $-769.0K | $4M | |
| Interest Income | $100.0K | · | $200.0K | · | $300.0K | · | $500.0K | · | · | · | · | $570.0K | $620.0K | · | $708.0K | $388.0K | |
| Other Non-op | $438.0K | $273.0K | $148.0K | $195.0K | $187.0K | $161.0K | $180.0K | $186.0K | $231.0K | $325.0K | $293.0K | $254.0K | $506.0K | $226.0K | $259.0K | $261.0K | |
| Pretax Income | $-6M | $-4M | $-11M | $-9M | $-34M | $-6M | $-242.0K | $925.0K | $5M | $-3M | $-3M | $1M | $-1M | $453.0K | $-211.0K | $4M | |
| Income Tax | $13.0K | $-102.0K | $11.0K | $9.0K | $9.0K | $6M | $465.0K | $-1M | $958.0K | $2M | $-618.0K | $565.0K | $-292.0K | $669.0K | $1.0K | $1M | |
| Net Income | $-6M | $-4M | $-11M | $-9M | $-34M | $-12M | $-707.0K | $2M | $4M | $-5M | $-2M | $715.0K | $-1M | $-216.0K | $-212.0K | $3M | |
| EPS (Basic) | $-0.28 | $-0.18 | $-0.50 | $-0.41 | $-1.65 | $-0.56 | $-0.03 | $0.11 | $0.18 | $-0.25 | $-0.10 | $0.04 | $-0.06 | $-0.01 | $-0.01 | $0.14 | |
| EPS (Diluted) | $-0.28 | $-0.18 | $-0.50 | $-0.41 | $-1.65 | $-0.56 | $-0.03 | $0.11 | $0.18 | $-0.24 | $-0.10 | $0.03 | $-0.06 | $-0.01 | $-0.01 | $0.14 | |
| Shares (Basic) | 21,682,381 | -41,731,700 | 21,008,521 | 20,889,124 | 20,755,416 | -41,149,717 | 20,634,651 | 20,597,807 | 20,513,281 | -40,744,828 | 20,425,282 | 20,382,979 | 20,332,526 | -40,495,712 | 20,301,384 | 20,261,114 | |
| Shares (Diluted) | 21,682,381 | -41,731,700 | 21,008,521 | 20,889,124 | 20,755,416 | -41,918,951 | 20,634,651 | 20,938,817 | 20,941,505 | -41,142,304 | 20,425,282 | 20,780,455 | 20,332,526 | -40,597,362 | 20,301,384 | 20,343,980 | |
| EBITDA | $-4M | · | $-8M | $-6M | $-32M | · | $1M | $2M | $6M | · | $-1M | $3M | $-450.0K | · | $-769.0K | $3M |
Neraca 23
| Metrik | Tren | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $21M | $27M | $36M | $41M | $55M | $50M | $52M | $46M | $55M | $49M | $53M | $62M | · | $102M | $97M | |
| Receivables | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | · | $2M | $2M | |
| Inventory | $8M | $14M | $12M | $15M | $18M | $16M | $12M | $13M | · | $29M | · | · | · | · | · | · | |
| Prepaid Expense | $4M | $6M | $8M | $6M | $6M | $5M | $4M | $4M | $4M | $6M | $9M | $10M | $9M | · | $6M | $5M | |
| Current Assets | $28M | $44M | $49M | $59M | $68M | $79M | $68M | $71M | $78M | $94M | $96M | $85M | $105M | · | $134M | $138M | |
| PP&E (Net) | $25M | $26M | $28M | $28M | $29M | $29M | $28M | $26M | $26M | $27M | $27M | $27M | $27M | · | $25M | $25M | |
| PP&E (Gross) | · | $58M | · | · | · | $54M | · | · | · | $47M | · | · | · | · | · | · | |
| Accum. Depreciation | · | $32M | · | · | · | $25M | · | · | · | $20M | · | · | · | · | · | · | |
| Goodwill | · | $0 | $0 | $0 | $0 | $27M | $27M | $27M | $27M | $27M | $27M | $27M | $27M | · | · | · | |
| Intangibles | $5M | $5M | $6M | $6M | $7M | $8M | $10M | $10M | $11M | $11M | $12M | $12M | $13M | · | · | · | |
| Total Assets | $64M | $81M | $88M | $100M | $110M | $149M | $145M | $146M | $153M | $170M | $173M | $163M | $184M | · | $165M | $169M | |
| Accounts Payable | $12M | $21M | $20M | $19M | $20M | $24M | $11M | $17M | $24M | $37M | $39M | $25M | $40M | · | $24M | $24M | |
| Current Liabilities | $41M | $52M | $55M | $57M | $58M | $63M | $48M | $49M | $58M | $72M | $72M | $61M | $79M | · | $31M | $31M | |
| Capital Leases | $0 | $42.0K | $167.0K | $291.0K | $414.0K | $535.0K | $652.0K | $768.0K | $883.0K | $995.0K | $890.0K | $1M | $1M | · | · | · | |
| Deferred Tax | $175.0K | $175.0K | $263.0K | $263.0K | $263.0K | $263.0K | · | · | · | $0 | · | · | $0 | · | $465.0K | $547.0K | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | · | · | · | |
| Total Liabilities | $41M | $52M | $55M | $57M | $58M | $64M | $49M | $50M | $59M | $73M | $73M | $62M | $80M | · | $32M | $31M | |
| Common Stock | $22.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | · | $21.0K | $21.0K | |
| Paid-in Capital | $20M | $20M | $19M | $19M | $19M | $19M | $18M | $18M | $17M | $25M | $23M | $22M | $20M | · | $17M | $15M | |
| Retained Earnings | $3M | $9M | $13M | $24M | $32M | $67M | $78M | $79M | $77M | $72M | $77M | $79M | $84M | · | $117M | $123M | |
| Stockholders' Equity | $23M | $29M | $33M | $43M | $52M | $85M | $96M | $96M | $94M | $97M | $100M | $100M | $104M | $110M | $134M | $138M | |
| Liabilities + Equity | $64M | $81M | $88M | $100M | $110M | $149M | $145M | $146M | $153M | $170M | $173M | $163M | $184M | · | $165M | $169M | |
| Shares Outstanding | 21,682,381 | 21,385,638 | 21,382,521 | 21,015,559 | 20,835,210 | 20,656,822 | 20,656,457 | 20,663,218 | 20,600,652 | 21,148,000 | 21,160,739 | 21,147,006 | 21,170,000 | 21,084,000 | 21,077,000 | 21,077,000 |
Arus Kas 13
| Metrik | Tren | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $994.0K | $941.0K | $858.0K | |
| Stock-based Comp | $198.0K | $274.0K | $300.0K | $200.0K | $591.0K | $518.0K | $500.0K | $600.0K | $-8M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Deferred Tax | · | $-88.0K | $0 | $0 | $0 | $5M | $465.0K | $-670.0K | $-26.0K | $728.0K | $-355.0K | $304.0K | $-627.0K | $-516.0K | $-725.0K | $-521.0K | |
| Amort. of Intangibles | $200.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $0 | $0 | $0 | |
| Other Non-cash | $-4M | · | · | · | $19M | · | · | · | $-6M | · | · | · | $-1M | · | · | · | |
| Operating Cash Flow | $-8M | $-5M | $-9M | $-2M | $-12M | $7M | $-1M | $7M | $-9M | $7M | $-3M | $-777.0K | $562.0K | $10M | $13M | $-1M | |
| CapEx | $641.0K | $720.0K | $-21.0K | $3M | $1M | $2M | $777.0K | $1M | $683.0K | $1M | $1M | $984.0K | $1M | $2M | $993.0K | $1M | |
| Investing Cash Flow | $-641.0K | $-720.0K | $21.0K | $-3M | $-1M | $-2M | $-777.0K | $-1M | $-683.0K | $-1M | $-1M | $-984.0K | $-37M | $-2M | $-993.0K | $-1M | |
| Dividends Paid | $0 | $-3.0K | $1.0K | $22.0K | $1.0K | $5.0K | $1.0K | $71.0K | $104.0K | $18.0K | $15.0K | $6M | $6M | $6M | $6M | $6M | |
| Financing Cash Flow | $-5.0K | $-38.0K | $0 | $-231.0K | $-30.0K | $-5.0K | $-1.0K | $-71.0K | $-104.0K | $-18.0K | $-15.0K | $-6M | $-6M | $-6M | $-6M | $-6M | |
| Net Change in Cash | $-8M | $-6M | $-9M | $-5M | $-14M | $5M | $-2M | $6M | $-9M | $6M | $-4M | $-8M | $-43M | $2M | $6M | $-9M | |
| Taxes Paid | $-120.0K | $-22.0K | $8.0K | $70.0K | $-4.0K | $51.0K | $8.0K | $385.0K | $81.0K | $87.0K | $43.0K | $0 | $0 | $442.0K | $1M | · | |
| Free Cash Flow | $-8M | · | · | · | $-14M | · | · | · | $-9M | · | · | · | $-591.0K | · | · | · |
Profitabilitas 8
| Metrik | Tren | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 27.6% | · | 23.3% | 28.0% | 28.1% | · | 28.1% | 29.1% | 26.5% | · | 27.4% | 28.3% | 28.8% | · | 25.9% | 28.2% | |
| Operating Margin | -15.2% | · | -25.8% | -18.9% | -66.7% | · | -0.85% | 0.93% | 6.5% | · | -4.7% | 1.2% | -2.7% | · | -1.3% | 4.5% | |
| Net Margin | -15.0% | · | -25.9% | -19.2% | -66.7% | · | -1.3% | 3.9% | 5.5% | · | -3.1% | 1.0% | -1.5% | · | -0.03% | 3.9% | |
| Pretax Margin | -14.9% | · | -25.9% | -19.2% | -66.7% | · | -0.46% | 1.6% | 6.9% | · | -4.0% | 1.8% | -1.8% | · | 0.34% | 5.5% | |
| EBITDA Margin | -10.0% | · | -19.9% | -13.8% | -62.2% | · | 2.1% | 3.7% | 9.0% | · | -2.0% | 3.6% | -0.58% | · | -1.3% | 4.5% | |
| ROA | -7.1% | · | -9.1% | -6.9% | -26.0% | · | -0.44% | 1.5% | 2.2% | · | -1.2% | 0.43% | -0.65% | · | -0.01% | 1.6% | |
| ROE | -16.5% | · | -16.4% | -12.2% | -47.1% | · | -0.72% | 2.4% | 3.8% | · | -1.7% | 0.60% | -0.93% | · | -0.01% | 1.8% | |
| ROIC | -27.2% | · | -32.0% | -19.5% | -66.2% | · | -1.4% | 1.4% | 3.7% | · | -2.4% | 0.49% | -1.6% | · | 0.06% | 1.5% |
Likuiditas & Solvabilitas 2
| Metrik | Tren | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.7 | · | 0.9 | 1.0 | 1.2 | · | 1.4 | 1.4 | 1.3 | · | 1.3 | 1.4 | 1.3 | · | 4.3 | 4.5 | |
| Quick Ratio | 0.4 | · | 0.5 | 0.7 | 0.7 | · | 1.1 | 1.1 | 0.8 | · | 0.7 | 0.9 | 0.8 | · | 3.4 | 3.2 |
Efisiensi 3
| Metrik | Tren | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | · | 0.3 | 0.4 | 0.4 | · | 0.3 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | |
| Inventory Turnover | 2.2 | · | · | 2.3 | 4.0 | · | 6.5 | 6.5 | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 24.8 | · | 21.3 | 24.7 | 26.5 | · | 25.3 | 31.4 | 32.7 | · | 33.7 | 37.7 | 42.6 | · | 36.7 | 38.0 |
Valuasi (TTM) 11
| Metrik | Tren | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $177M | · | $188M | $206M | $227M | · | $240M | $257M | $275M | · | $266M | $266M | $264M | · | $254M | $257M | |
| Net Income TTM | $-59M | · | $-54M | $-41M | $-29M | · | $3M | $5M | $1M | · | $-3M | $2M | $4M | · | $11M | $15M | |
| Market Cap | $42M | · | $68M | $53M | $69M | · | $100M | $76M | $83M | · | $160M | $217M | $292M | · | $373M | $411M | |
| P/E | -0.7 | · | -1.2 | -1.3 | -2.4 | · | 30.1 | 16.7 | 81.0 | · | -54.0 | 102.5 | 69.0 | · | 31.6 | 25.0 | |
| P/S | 0.2 | · | 0.4 | 0.3 | 0.3 | · | 0.4 | 0.3 | 0.3 | · | 0.6 | 0.8 | 1.1 | · | 1.5 | 1.6 | |
| P/B | 1.8 | · | 2.1 | 1.2 | 1.3 | · | 1.0 | 0.8 | 0.9 | · | 1.6 | 2.2 | 2.8 | · | 2.8 | 3.0 | |
| P / Tangible Book | 2.3 | · | 2.6 | 1.4 | 1.6 | · | 1.7 | 1.3 | 1.5 | · | 2.6 | 3.5 | 4.5 | · | 2.8 | 3.0 | |
| P / Cash Flow | -5.4 | · | · | · | -5.6 | · | · | · | -9.8 | · | · | · | 519.5 | · | · | · | |
| P / FCF | -5.0 | · | · | · | -5.1 | · | · | · | -9.1 | · | · | · | -494.0 | · | · | · | |
| Earnings Yield | -147.9% | · | -80.9% | -78.9% | -41.9% | · | 3.3% | 6.0% | 1.2% | · | -1.8% | 0.98% | 1.5% | · | 3.2% | 4.0% | |
| Payout Ratio | 0.00% | · | · | · | 0.00% | · | · | · | 2.8% | · | · | · | -537.1% | · | · | · |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Laporan Laba Rugi
| 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-12-31 | |
|---|---|---|---|---|---|
| Pendapatan | $179M | $227M | $274M | $248M | — |
| Margin Kotor % | 28.1% | 30.5% | 28.0% | 27.6% | — |
| Margin Operasi % | -32.8% | -0.67% | -2.9% | 2.4% | — |
| Laba Bersih | $-57M | $-6M | $-7M | $5M | — |
| EPS Dilusian | $-2.74 | $-0.30 | $-0.37 | $0.25 | — |
Neraca
| 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-12-31 | |
|---|---|---|---|---|---|
| Rasio Lancar | 0.8 | 1.3 | 1.3 | — | — |
| Rasio Cepat | 0.4 | 0.9 | 0.8 | — | — |
Arus Kas
| 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-12-31 | |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-33M | $-395.0K | $-194.0K | $23M | — |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Pemilik institusional (13F) 56 pengaju · $8.0M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 14 (+4 vs Kuartal sebelumnya) | 8 (-2 vs Kuartal sebelumnya) | 9 (-2 vs Kuartal sebelumnya) | 16 (+2 vs Kuartal sebelumnya) | -849K |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | $2.171.962 | 1.131.230 | 27,26% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.588.602 | 827.397 | 19,94% | Saham |
| STEEL PARTNERS HOLDINGS L.P. | $371.835 | 193.664 | 4,67% | Saham |
| VANGUARD GROUP INC | $351.078 | 109.712 | 4,41% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $306.987 | 159.825 | 3,85% | Saham |
| HTLF Bank | $289.200 | 60.000 | 3,63% | Saham |
| UBS Group AG | $258.678 | 134.728 | 3,25% | Saham |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $232.412 | 121.048 | 2,92% | Saham |
| Rangeley Capital, LLC | $232.320 | 121.000 | 2,92% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $212.124 | 110.481 | 2,66% | Saham |
| STATE STREET CORP | $201.932 | 105.173 | 2,53% | Saham |
| Formidable Asset Management, LLC | $195.056 | 85.551 | 2,45% | Saham |
| Empowered Funds, LLC | $158.108 | 82.348 | 1,98% | Saham |
| TUDOR INVESTMENT CORP ET AL | $156.301 | 81.407 | 1,96% | Saham |
| FEDERATED HERMES, INC. | $154.833 | 80.642 | 1,94% | Saham |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $152.646 | 79.503 | 1,92% | Saham |
| CITADEL ADVISORS LLC | $142.324 | 74.127 | 1,79% | Saham |
| UMB Bank, n.a. | $115.200 | 60.000 | 1,45% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $92.796 | 48.331 | 1,16% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $91.647 | 47.733 | 1,15% | Saham |
| NORTHERN TRUST CORP | $81.519 | 42.458 | 1,02% | Saham |
| XTX Topco Ltd | $80.511 | 41.933 | 1,01% | Saham |
| CIBC Private Wealth Group LLC | $75.300 | 30.000 | 0,95% | Saham |
| SIMPLEX TRADING, LLC | $47.702 | 24.845 | 0,60% | Saham |
| IMC-Chicago, LLC | $44.014 | 22.924 | 0,55% | Saham |
| TUDOR INVESTMENT CORP ET AL | $29.568 | 15.400 | 0,37% | Opsi beli |
| Jain Global LLC | $26.148 | 13.619 | 0,33% | Saham |
| AMERICAN CENTURY COMPANIES INC | $24.712 | 12.871 | 0,31% | Saham |
| MORGAN STANLEY | $21.875 | 11.393 | 0,27% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $17.637 | 9.186 | 0,22% | Saham |
| Vanguard Global Advisers, LLC | $15.590 | 8.120 | 0,20% | Saham |
| BlackRock, Inc. | $6.947 | 3.618 | 0,09% | Saham |
| OSAIC HOLDINGS, INC. | $6.772 | 3.527 | 0,09% | Saham |
| SBI Securities Co., Ltd. | $2.148 | 1.119 | 0,03% | Saham |
| Bank & Trust Co | $2.054 | 901 | 0,03% | Saham |
| HARBOUR INVESTMENTS, INC. | $1.037 | 540 | 0,01% | Saham |
| Accredited Wealth Management, LLC | $1.004 | 5.636 | 0,01% | Saham |
| Allworth Financial LP | $949 | 494 | 0,01% | Saham |
| MCF Advisors LLC | $768 | 400 | 0,01% | Saham |
| JONES FINANCIAL COMPANIES LLLP | $730 | 415 | 0,01% | Saham |
| Ascentis Independent Advisors | $683 | 356 | 0,01% | Saham |
| WELLS FARGO & COMPANY/MN | $577 | 300 | 0,01% | Saham |
| ROTHSCHILD INVESTMENT LLC | $480 | 250 | 0,01% | Saham |
| Tower Research Capital LLC (TRC) | $323 | 168 | 0,00% | Saham |
| Farther Finance Advisors, LLC | $290 | 151 | 0,00% | Saham |
| PRICE T ROWE ASSOCIATES INC /MD/ | $250 | 129.933 | 0,00% | Saham |
| Integrated Wealth Concepts LLC | $198 | 103 | 0,00% | Saham |
| FMR LLC | $115 | 60 | 0,00% | Saham |
| Elevated Capital Advisors, LLC | $96 | 50 | 0,00% | Saham |
| PROEQUITIES, INC. | $70 | 14 | 0,00% | Saham |
| Caitong International Asset Management Co., Ltd | $23 | 12 | 0,00% | Saham |
| CITIGROUP INC | $17 | 9 | 0,00% | Saham |
| CoreCap Advisors, LLC | $8 | 4 | 0,00% | Saham |
| Steward Partners Investment Advisory, LLC | $4 | 2 | 0,00% | Saham |
| HUNTINGTON NATIONAL BANK | $2 | 1 | 0,00% | Saham |
| ROYAL BANK OF CANADA | $0 | 30 | 0,00% | Saham |
Orang dalam perusahaan 24 orang dalam · 5 pejabat · 9 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Sandra Yvette Campos | CEO & President | 30 April 2025 S | 578.524 | 0 | 0 | $0 |
| Menderes Akdag | CEO & President | 16 Maret 2013 A | 628.000 | 0 | 0 | $0 |
| Douglas Krulik | CAO and Interim CFO | 26 Juni 2026 A | 102.500 | 0 | 0 | $0 |
| Robyn M. D'Elia | Chief Financial Officer | 27 Sep. 2024 A | 250.000 | 0 | 0 | $0 |
| Christine Chambers | CFO | 31 Mei 2024 D | 65.146 | 0 | 0 | $0 |
| Gian Fulgoni | Direktur | 21 Jan. 2026 D | 132.299 | 0 | 0 | $0 |
| Leah Solivan | Direktur | 8 Agu 2024 A | 8.443 | 0 | 0 | $0 |
| Diana G Purcel | Direktur | 8 Agu 2024 A | 24.375 | 0 | 0 | $0 |
| Ronald J Korn | Direktur | 18 Maret 2013 S | 67.333 | 0 | 0 | $0 |
| Frank J Formica | Direktur | 27 Juli 2012 A | 45.500 | 0 | 0 | $0 |
| Robert C Schweitzer | Direktur | 27 Juli 2012 A | 65.834 | 0 | 0 | $0 |
| Marc Puleo MD | Direktur | 16 Agu 2005 J | 913.286 | 0 | 0 | $0 |
| TRICON HOLDINGS LLC | Pemilik 10% | 4 Agu 2006 S | 2.284.000 | 0 | 0 | $0 |
| Peter Batushansky | — | 11 Agu 2026 A | 91.928 | 0 | 0 | $0 |
| James Lacamp | — | 11 Agu 2026 A | 90.421 | 0 | 0 | $0 |
| Justin L. Mennen | — | 11 Agu 2026 A | 98.274 | 0 | 0 | $0 |
| Leslie C.G. Campbell | — | 11 Agu 2026 A | 145.000 | 0 | 0 | $0 |
| Jacqueline Paula Smith | — | 15 Jan. 2025 A | 28.099 | 0 | 0 | $0 |
| Mathew N Hulett | — | 29 April 2024 D | 103.850 | 0 | 0 | $0 |
| Mark Bradley Moseley JR | — | 11 Des. 2023 A | 42.000 | 0 | 0 | $0 |
| Daniel Job Pingree | — | 17 Mei 2023 A | 22.000 | 0 | 0 | $0 |
| Bruce S Rosenbloom | — | 18 Maret 2013 S | 46.100 | 0 | 0 | $0 |
| CRESLIN LTD | — | 4 Agu 2006 S | 2.284.000 | 0 | 0 | $0 |
| Guven Kivilcim | — | 22 Jan. 2004 S | 1.310.300 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Aktivis & pemilik 5%+ 2 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| SilverCape Investments Limited, Peter Kennedy ×3 pengajuan | 29 Juni 2026 | 12,07% | Amandemen | Investasi pasif | SEC |
| Diveroli Investment Group LLC, Kingbird Ventures LLC | 11 Feb. 2026 | 1,83% | Pengajuan awal | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Kepemilikan ETF Dimiliki oleh 25 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| FSCC · Federated Hermes ETF Trust | 0,06% | 75.863 NS | 31 Mei 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 12.060 NS | 31 Mei 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 53.484 NS | 30 April 2026 | N-PORT |
| AVUV · AMERICAN CENTURY ETF TRUST | 0,00% | 605 NS | 31 Mei 2026 | N-PORT |
| AVSU · AMERICAN CENTURY ETF TRUST | 0,00% | 18 NS | 31 Mei 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15 Juli 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | — | — | 15 Juli 2026 | Harian |
| VXUS · VANGUARD STAR FUNDS | — | — | 15 Juli 2026 | Harian |
| VGK · VANGUARD INTERNATIONAL EQUITY INDEX… | — | — | 15 Juli 2026 | Harian |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | — | — | 15 Juli 2026 | Harian |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | — | — | 15 Juli 2026 | Harian |
| VEA · VANGUARD TAX-MANAGED FUNDS | — | — | 15 Juli 2026 | Harian |
| IWC · iShares Trust | — | — | 18 Agu 2026 | Harian |
| ISVL · iShares Trust | — | — | 20 Juli 2026 | Harian |
| PDN · Invesco Exchange-Traded Fund Trust … | — | — | 13 Juli 2026 | Harian |
| VSGX · VANGUARD WORLD FUND | — | — | 30 Juli 2026 | Harian |
| IEUS · iShares Trust | — | — | 5 Agu 2026 | Harian |
| SCZ · iShares Trust | — | — | 18 Agu 2026 | Harian |
| EWUS · iShares Trust | — | — | 20 Juli 2026 | Harian |
| IEFA · iShares Trust | — | — | 24 Juli 2026 | Harian |
| IXUS · iShares Trust | — | — | 17 Agu 2026 | Harian |
| IEUR · iShares Trust | — | — | 17 Agu 2026 | Harian |
| ISCF · iShares Trust | — | — | 20 Juli 2026 | Harian |
| IDEV · iShares Trust | — | — | 22 Juli 2026 | Harian |
| WSML · iShares Trust | — | — | 20 Juli 2026 | Harian |